The AACR Annual Meeting covers the cancer research spectrum from the bench to the clinic. As such, we are extremely pleased to be featuring a clinical trial of a novel drug that is showing great promise for breast cancer patients in our opening plenary session, Harnessing Breakthroughs, Targeting Cures.
- Final results of a randomized Phase II study of PD 0332991, a cyclin-dependent kinase (CDK)-4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1; TRIO-18)
AACR has a long-standing commitment to highlighting the best science-based clinical research and will continue this tradition by once again offering four Clinical Trials Symposia featuring four clinical trials each, with an in-depth discussion of the science behind the trial following each presentation.
Additionally, many interesting clinical studies will be presented in Clinical Trials Minisymposia:
Further, there are opportunities to see even more clinical studies in Clinical Trials Poster Sessions in Hall A-E of the San Diego Convention Center.
Click here to access the AACR Annual Meeting 2014 program online or to download the Annual Meeting App.
AACR Annual Meeting 2014 • April 5-9, 2014 • San Diego Convention Center • San Diego, California